Cargando…

Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma

This paper is a report of response rate (RR) and survival of 34 metastatic melanoma patients who received a dinitrophenyl (DNP)-modified autologous melanoma cell vaccine. In all, 27 patients started the vaccine as a primary treatment for metastatic melanoma and seven started it as an adjuvant, with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lotem, M, Shiloni, E, Pappo, I, Drize, O, Hamburger, T, Weitzen, R, Isacson, R, Kaduri, L, Merims, S, Frankenburg, S, Peretz, T
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410164/ https://www.ncbi.nlm.nih.gov/pubmed/14970852 http://dx.doi.org/10.1038/sj.bjc.6601563

Ejemplares similares

Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV)
por: Lotem, M, et al.
Publicado: (2002)

Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
por: Lotem, Michal, et al.
Publicado: (2016)

Human T Cell Crosstalk Is Induced by Tumor Membrane Transfer
por: Uzana, Ronny, et al.
Publicado: (2015)

Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study
por: Hadash-Bengad, Reut, et al.
Publicado: (2020)

Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients
por: Hirshoren, Nir, et al.
Publicado: (2020)

Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients
por: Sivan, Sapoznik, et al.
Publicado: (2012)

DNP 2017
Publicado: (2017)

Dermatological adverse events under programmed cell death‐1 inhibitors as a prognostic marker in metastatic melanoma
por: Shreberk‐Hassidim, Rony, et al.
Publicado: (2022)

An Enhanced Actualized DNP Model to Improve DNP Project Placements, Rigor, and Completion
por: VanderKooi, Marie E., et al.
Publicado: (2018)

SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint
por: Hajaj, Emma, et al.
Publicado: (2020)

Leadership and systems improvement for the DNP
por: Armstrong, Gail, et al.
Publicado: (2019)

Dendritic polarizing agents for DNP SENS
por: Liao, Wei-Chih, et al.
Publicado: (2017)

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor
Publicado: (1988)

DNp73: oncotarget in invasion and metastasis
por: Pützer, Brigitte M.
Publicado: (2013)

STUDIES ON ARTIFICIAL ANTIGENS : I. ANTIGENICITY OF DNP-POLYLYSINE AND DNP COPOLYMER OF LYSINE AND GLUTAMIC ACID IN GUINEA PIGS
por: Kantor, Fred S., et al.
Publicado: (1963)

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
por: Ellebaek, Eva, et al.
Publicado: (2012)

Organizing pneumonia following treatment with pembrolizumab for metastatic malignant melanoma – A case report
por: Kuint, R., et al.
Publicado: (2017)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
por: Svane, I, et al.
Publicado: (2014)

Jacqueline Herd DNP, RN, NEA-BC
por: Shinkus Clark, Joan
Publicado: (2020)

Targeted DNP for biomolecular solid-state NMR
por: Gauto, Diego, et al.
Publicado: (2021)

A STUDY OF THE PASSIVE TRANSFER OF DELAYED HYPERSENSITIVITY TO DNP-POLY-L-LYSINE AND DNP-GL IN RESPONDER AND NONRESPONDER GUINEA PIGS
por: Green, Ira, et al.
Publicado: (1967)

Quenching of Tryptophan Fluorescence in the Presence of 2,4-DNP, 2,6-DNP, 2,4-DNA and DNOC and Their Mechanism of Toxicity
por: Huţanu, Cristina-Amalia Dumitraş, et al.
Publicado: (2013)

Continuous-flow DNP polarizer for MRI applications at 1.5 T
por: Denysenkov, V., et al.
Publicado: (2017)

CELLULAR REQUIREMENTS FOR THE PRIMARY IN VITRO ANTIBODY RESPONSE TO DNP-FICOLL
por: Mosier, D. E., et al.
Publicado: (1974)

CELLULAR LOCALIZATION OF ANTI-DNP-PLL AND ANTICONVEYOR ALBUMIN ANTIBODIES IN GENETIC NONRESPONDER GUINEA PIGS IMMUNIZED WITH DNP-PLL ALBUMIN COMPLEXES
por: Green, Ira, et al.
Publicado: (1967)

The immune response of allophenic mice to 2,4-dinitrophenyl (DNP)-bovine gamma globulin. I. Allotype analysis of anti-DNP antibody
por: Warner, CM, et al.
Publicado: (1978)

Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.
por: Baxevanis, C. N., et al.
Publicado: (1994)

Electron-decoupled MAS DNP with N@C(60)
por: Alaniva, Nicholas, et al.
Publicado: (2023)

Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes
por: Håkansson, A, et al.
Publicado: (2001)

Single-agent interleukin-2 in the treatment of metastatic melanoma
por: Petrella, T., et al.
Publicado: (2007)

Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.
por: Håkansson, A., et al.
Publicado: (1996)

Polymorphs of Theophylline Characterized by DNP Enhanced Solid-State NMR
por: Pinon, Arthur C., et al.
Publicado: (2015)

Microfluidic Overhauser DNP chip for signal-enhanced compact NMR
por: Kiss, Sebastian Z., et al.
Publicado: (2021)

Practical modern SCADA protocols: DNP3, 60870.5 and related systems
por: Clarke, Gordon R, et al.
Publicado: (2004)

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma
Publicado: (1988)

Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
por: Nicol, A J, et al.
Publicado: (2011)

Russian roulette with unlicensed fat-burner drug 2,4-dinitrophenol (DNP): evidence from a multidisciplinary study of the internet, bodybuilding supplements and DNP users
por: Petróczi, Andrea, et al.
Publicado: (2015)

Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma
por: Klein, M., et al.
Publicado: (2013)

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
por: McEvoy, Ashleigh C., et al.
Publicado: (2018)

Tumour to Tumour Metastasis of Malignant Melanoma to Intracranial Tumour
por: Shariff, Zakir, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3c33n2pvjg2kijvtg28nim46vd